#News for #investors and #media: We’re proud to rank 2nd overall in the Access to Medicines Index, reflecting our ongoing commitment to ensuring vital medicines and vaccines reach people who need them: gsk.to/4zF8ph2
#News for #Investors and #Media: At #TLM26 we’re unveiling our latest advancements across our hepatology pipeline for chronic hepatitis B (CHB), metabolic dysfunction-associated steatohepatitis (MASH), and alcohol-related liver disease (ALD).